LMAT
$112.23
LeMaitre Vascular, Inc.
Intraday
Recent News
3 Cash-Producing Stocks with Warning Signs
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
3 Healthcare Stocks We’re Skeptical Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 3.8%, nearly mirrorring the S&P 500.
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed?
In late February 2026, LeMaitre Vascular reported higher fourth-quarter and full-year 2025 sales and earnings, raised its quarterly dividend to US$0.25 per share, issued upbeat 2026 guidance, and authorized a new US$100 million share repurchase program running through February 18, 2027. Together, the stronger results, higher capital returns, and confident outlook highlight management’s emphasis on balancing business expansion with returning cash to shareholders. Next, we’ll explore how the...